NB-UVB and PUVA Vitiligo Study
Completed · Phase 4
Conditions studied: Vitiligo
In brief
To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
Key facts
- Study ID
- NCT01732965
- Run by
- Henry Ford Health System
- People needed
- 10
- Starts
- 2013-03-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2017-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Vitiligo affecting more than 15% body surface area.
Where it is running
- Henry Ford Dermatology — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.